One of UPMC’s most prominent physicians is no longer employed by the medical center or the University of Pittsburgh.

Robert Friedlander was the chair of Pitt’s department of neurological surgery and the Walter E. Dandy distinguished professor of neurosurgery, neurology and neurobiology. He was also co-chair of the UPMC Neurological Institute.

“Dr. Robert Friedlander has stepped down as Chair of the Department of Neurological Surgery and is no longer affiliated with UPMC or the University of Pittsburgh,” UPMC said in an emailed statement. “Dr. Edith Tzeng will serve as the interim chair of the department.”

Dr. Friedlander came to Pittsburgh in 2010 after graduating from Harvard Medical School and completing his residency and fellowship at Massachusetts General Hospital. Born in Venezuela, Dr. Friedlander came to America in 1983 to attend Brandeis University, where he earned bachelor’s and master’s degrees in biochemistry.

Advertise with us

He was one of UPMC’s highest-paid physicians, receiving more than $1.7 million in 2023 from the medical center, according to its most recent annual 990 disclosure form. He also brought in millions of dollars in research grant funding to Pitt over his tenure there. He is the founder of one biotech company, Helexva, and was the chair of the scientific advisory board for another biotech company, NeuBase Therapeutics, which disbanded in 2024.

Most of the online record of Dr. Friedlander’s time at Pitt and UPMC is no longer accessible.

Read More

Links to his biography pages and press releases about his research findings either go to a “page not found” error or to the general website for Pitt’s department of neurological surgery.

An announcement earlier this week of his departure has also been taken down from Pitt’s website.

At Pitt, Dr. Friedlander built a specialty treating patients with aneurysms, vascular malformations and brain tumors. Dr. Friedlander was an expert on a condition called Chiari malformation, in which brain tissue extends into the spinal canal. Last year, he published a review article on Chiari syndrome in the New England Journal of Medicine.

Advertise with us

Members of a Chiari malformation Facebook group, some of whom had traveled hours for surgery and follow-up from Dr. Friedlander, expressed confusion this week about his sudden departure and concern about the fate of their scheduled appointments.

Dr. Tzeng, a vascular surgeon who will serve as the interim chair of the neurological surgery department, is a UPMC professor of surgery and head of vascular surgery at the VA Pittsburgh Healthcare System.